Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Shionogi signs license agreement with Tokushima University for novel type A2 Botulinum toxin

Nov. 25, 2016

Novel dexamethasone prodrug ZSJ-0228 has lower systemic exposure, improved safety

Nov. 25, 2016

EMA grants positive opinion for teriparatide biosimilar

Nov. 17, 2016

Novel optimized mouse model of cyclophosphamide-induced bone marrow suppression

Nov. 16, 2016

Resunab demonstrates clinical benefit in phase II trial in systemic sclerosis

Nov. 16, 2016

FDA awards orphan drug designation to ECCS-50 for scleroderma

Nov. 15, 2016

Medshine Discovery presents JAK2 inhibitors

Nov. 14, 2016

Mabion signs development and commercialization agreement with Mylan for Mabion-CD20

Nov. 10, 2016

ReVance Therapeutics initiates phase II trial of RT-002 in plantar fasciitis

Nov. 4, 2016

Mitsubishi Tanabe and Kolon Life Science sign licensing agreement for Invossa in Japan

Nov. 2, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...